By subcutaneously implanting restoration of Cdk2-/- cancer cells with WT Cdk2 or Cdk2T160A into C57 mice, we observed that the combination of Cdk2T160A cells with MTX remained more effective than the replenished Cdk2-/- cancer cells. This evidence concerns the gene CDK2 and cancer.